Gastroparesis (GP) is a chronic disorder of the stomach which presents with early satiety, nausea, vomiting, bloating, and upper abdominal discomfort and is characterized by delayed gastric emptying.
Normal gastric emptying reflects a coordinated effort between different regions of the stomach and the duodenum as well as extrinsic modulation by central nervous system (CNS) and distal gut factors.
GP disrupts this coordinated contractile effort. Female account for up to 82% of the affected patients. Diabetic patients constitute around 30-35% of GP patients and it is estimated that up to 50% of type I (insulin dependent) diabetics and 30% of type 2 (noninsulin dependent) diabetics have symptoms consistent with GP.
G-POEM
G-POEM involves releasing the valve that regulates the entry of the food from the stomach to the duodenum (pylorus). This is done endoscopically without any surgical incision and discharge is usually the same day of the operation.
Gastric stimulator
The gastric neurostimulator is a programmable device that generates mild electrical pulses for gastric electrical stimulation to treat chronic, intractable nausea and vomiting due to gastroparesis.
This small, battery-powered gastric neurostimulator is implanted beneath the skin in the lower abdominal region. The neurostimulator generates controlled electrical pulses delivered by leads to the antrum portion of the stomach muscle wall. After implant, the clinician optimizes therapy for the patient with a clinician programmer.
Minimally invasive options
If previous options or medications do not relieve your symptoms several other minimally invasive robotic options are available to improve your symptoms.